胃癌、胰臟癌 Gastric cancer:
Treatment of disseminated adenocarcinoma of the stomach (in combination with other chemotherapy agents) and as palliative treatment when other modalities have failed. Pancreatic cancer:
Treatment of disseminated adenocarcinoma of the pancreas (in combination with other chemotherapy agents) and as palliative treatment when other modalities have failed. * Limitations of use: Not recommended for single-agent primary therapy or to replace appropriate surgery and/or radiotherapy in the treatment of these conditions.
藥理
Antineoplastic agents, DNA alkylator
Mitomycin alkylates DNA to produce DNA cross-linking (primarily with guanine and cytosine pairs) and inhibits DNA and RNA synthesis. Mitomycin is not cell cycle specific but has its maximum effect against cells in late G and early S phases.
1. Hypersensitivity to mitomycin or any component of the formulation
2. Thrombocytopenia; Coagulation disorders,or other increased bleeding tendency
懷孕分類
Adverse events have been observed in animal reproduction studies.
哺乳分類
1.It is not known if mitomycin is present in breast milk. 2.Due to the potential for serious adverse reactions in the breastfed infant, breastfeeding is not recommended by the manufacturer.